Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0161562
Title: Renal dysfunction during tenofovir use in a regional cohort of HIV-infected individuals in the Asia-Pacific
Authors: Tanuma J.
Jiamsakul A.
Makane A.
Avihingsanon A.
Ng O.T. 
Kiertiburanakul S.
Chaiwarith R.
Kumarasamy N.
Van Nguyen K.
Pham T.T.
Lee M.P.
Ditangco R.
Merati T.P.
Choi J.Y.
Wong W.W.
Kamarulzaman A.
Yunihastuti E.
Sim B.L.
Ratanasuwan W.
Kantipong P.
Zhang F.
Mustafa M.
Saphonn V.
Pujari S.
Sohn A.H.
Mean C.V.
Saphonn V.
Vohith K.
Zhang F.J.
Zhao H.X.
Han N.
Li P.C.K.
Lam W.
Chan Y.T.
Wong K.H.
Saghayam S.
Ezhilarasi C.
Joshi K.
Wirawan D.N.
Yuliana F.
Imran D.
Widhani A.
Oka S.
Nishijima T.
Na S.
Kim J.M.
Gani Y.M.
David R.
Omar S.F.S.
Ponnampalavanar S.
Azwa I.
Huda N.
Ong L.Y.
Uy E.
Bantique R.
Ku W.W.
Wu P.C.
Lim P.L. 
Lee L.S.
Ohnmar P.S.
Phanuphak P.
Ruxrungtham K.
Chusut P.
Sirivichayakul S.
Sungkanuparph S.
Chumla L.
Sanmeema N.
Chaiwarith R.
Sirisanthana T.
Kotarathititum W.
Praparattanapan J.
Kantipong P.
Kambua P.
Sriondee R.
Bui V.H.
Cao T.T.
Cuong D.D.
Ha H.L.
Durier N.
Petersen B.
Singtoroj T.
Cooper D.A.
Law M.G.
Boettiger D.C.
Keywords: creatinine
proteinase inhibitor
tenofovir
anti human immunodeficiency virus agent
creatinine
tenofovir
adult
aging
Article
Asia
cohort analysis
creatinine blood level
drug efficacy
estimated glomerular filtration rate
female
human
Human immunodeficiency virus infected patient
Human immunodeficiency virus infection
incidence
kidney dysfunction
major clinical study
male
middle aged
Pacific islands
prevalence
proportional hazards model
renal protection
risk factor
blood
chemically induced
drug effects
factual database
glomerulus filtration rate
HIV Infections
kidney
kidney disease
pathophysiology
Poisson distribution
prospective study
Adult
Anti-HIV Agents
Creatinine
Databases, Factual
Female
Glomerular Filtration Rate
HIV Infections
Humans
Kidney
Kidney Diseases
Male
Middle Aged
Poisson Distribution
Proportional Hazards Models
Prospective Studies
Risk Factors
Tenofovir
Issue Date: 2016
Citation: Tanuma J., Jiamsakul A., Makane A., Avihingsanon A., Ng O.T., Kiertiburanakul S., Chaiwarith R., Kumarasamy N., Van Nguyen K., Pham T.T., Lee M.P., Ditangco R., Merati T.P., Choi J.Y., Wong W.W., Kamarulzaman A., Yunihastuti E., Sim B.L., Ratanasuwan W., Kantipong P., Zhang F., Mustafa M., Saphonn V., Pujari S., Sohn A.H., Mean C.V., Saphonn V., Vohith K., Zhang F.J., Zhao H.X., Han N., Li P.C.K., Lam W., Chan Y.T., Wong K.H., Saghayam S., Ezhilarasi C., Joshi K., Wirawan D.N., Yuliana F., Imran D., Widhani A., Oka S., Nishijima T., Na S., Kim J.M., Gani Y.M., David R., Omar S.F.S., Ponnampalavanar S., Azwa I., Huda N., Ong L.Y., Uy E., Bantique R., Ku W.W., Wu P.C., Lim P.L., Lee L.S., Ohnmar P.S., Phanuphak P., Ruxrungtham K., Chusut P., Sirivichayakul S., Sungkanuparph S., Chumla L., Sanmeema N., Chaiwarith R., Sirisanthana T., Kotarathititum W., Praparattanapan J., Kantipong P., Kambua P., Sriondee R., Bui V.H., Cao T.T., Cuong D.D., Ha H.L., Durier N., Petersen B., Singtoroj T., Cooper D.A., Law M.G., Boettiger D.C. (2016). Renal dysfunction during tenofovir use in a regional cohort of HIV-infected individuals in the Asia-Pacific. PLoS ONE 11 (8) : e0161562. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0161562
Rights: Attribution 4.0 International
Abstract: Background: In resource-limited settings, routine monitoring of renal function during antiretroviral therapy (ART) has not been recommended. However, concerns for tenofovir disoproxil fumarate (TDF)-related nephrotoxicity persist with increased use. Methods: We investigated serum creatinine (S-Cr) monitoring rates before and during ART and the incidence and prevalence of renal dysfunction after starting TDF by using data from a regional cohort of HIV-infected individuals in the Asia-Pacific. Time to renal dysfunction was defined as time from TDF initiation to the decline in estimated glomerular filtration rate (eGFR) to <60 ml/min/1.73m2 with >30% reduction from baseline using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation or the decision to stop TDF for reported TDF-nephrotoxicity. Predictors of S-Cr monitoring rates were assessed by Poisson regression and risk factors for developing renal dysfunction were assessed by Cox regression. Results: Among 2,425 patients who received TDF, S-Cr monitoring rates increased from 1.01 to 1.84 per person per year after starting TDF (incidence rate ratio 1.68, 95%CI 1.62-1.74, p <0.001). Renal dysfunction on TDF occurred in 103 patients over 5,368 person-years of TDF use (4.2%; incidence 1.75 per 100 person-years). Risk factors for developing renal dysfunction included older age (>50 vs. ?30, hazard ratio [HR] 5.39, 95%CI 2.52-11.50, p <0.001; and using PI-based regimen (HR 1.93, 95%CI 1.22-3.07, p = 0.005). Having an eGFR prior to TDF (pre-TDF eGFR) of ?60 ml/min/1.73m2 showed a protective effect (HR 0.38, 95%CI, 0.17-0.85, p = 0.018). Conclusions: Renal dysfunction on commencing TDF use was not common, however, older age, lower baseline eGFR and PI-based ART were associated with higher risk of renal dysfunction during TDF use in adult HIV-infected individuals in the Asia-Pacific region. © 2016 Tanuma et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Source Title: PLoS ONE
URI: https://scholarbank.nus.edu.sg/handle/10635/161559
ISSN: 19326203
DOI: 10.1371/journal.pone.0161562
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1371_journal_pone_0161562.pdf220.25 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons